메뉴 건너뛰기




Volumn 102, Issue 1, 2004, Pages 37-46

Signaling through the epidermal growth factor receptor during the development of malignancy

Author keywords

Carcinogenesis; EGF; EGFR; Epidermal growth factor; Epidermal growth factor receptor; G protein coupled receptor; GPCR; MAPK; Mitogen activated protein kinase; Monotherapy; PI3 kinase; PI3K; PLC ; Signaling

Indexed keywords

6 (4 HYDROXYPHENYL) 4 (ALPHA METHYLBENZYLAMINO) 7H PYRROLO[2,3 D]PYRIMIDINE; CANERTINIB; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; ERLOTINIB; GEFITINIB; H R3; LAPATINIB; MDX 447; PANITUMUMAB; PELITINIB; UNCLASSIFIED DRUG;

EID: 1842471336     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2004.01.002     Document Type: Review
Times cited : (258)

References (90)
  • 3
    • 0032579405 scopus 로고    scopus 로고
    • Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor
    • Antonyak M.A., Moscatello D.K., Wong A.J. Constitutive activation of c-Jun N-terminal kinase by a mutant epidermal growth factor receptor. J Biol Chem. 273(5):1998;2817-2822.
    • (1998) J Biol Chem , vol.273 , Issue.5 , pp. 2817-2822
    • Antonyak, M.A.1    Moscatello, D.K.2    Wong, A.J.3
  • 4
    • 0025605344 scopus 로고
    • The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily
    • Aroian R.V., Koga M., Mendel J.E., Ohshima Y., Sternberg P.W. The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily. Nature. 348(6303):1990;693-699.
    • (1990) Nature , vol.348 , Issue.6303 , pp. 693-699
    • Aroian, R.V.1    Koga, M.2    Mendel, J.E.3    Ohshima, Y.4    Sternberg, P.W.5
  • 5
    • 18544380391 scopus 로고    scopus 로고
    • Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas
    • Bankfalvi A., Krassort M., Vegh A., Felszeghy E., Piffko J. Deranged expression of the E-cadherin/beta-catenin complex and the epidermal growth factor receptor in the clinical evolution and progression of oral squamous cell carcinomas. J Oral Pathol Med. 31(8):2002;450-457.
    • (2002) J Oral Pathol Med , vol.31 , Issue.8 , pp. 450-457
    • Bankfalvi, A.1    Krassort, M.2    Vegh, A.3    Felszeghy, E.4    Piffko, J.5
  • 7
    • 0036362181 scopus 로고    scopus 로고
    • Why the epidermal growth factor receptor? the rationale for cancer therapy
    • Baselga J. Why the epidermal growth factor receptor? The rationale for cancer therapy. Oncologist. 7(Suppl. 4):2002;2-8.
    • (2002) Oncologist , vol.7 , Issue.SUPPL. 4 , pp. 2-8
    • Baselga, J.1
  • 8
    • 0028863853 scopus 로고
    • Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene
    • Batra S.K., Castelino-Prabhu S., Wikstrand C.J., Zhu X., Humphrey P.A., Friedman H.S., Bigner D.D. Epidermal growth factor ligand-independent, unregulated, cell-transforming potential of a naturally occurring human mutant EGFRvIII gene. Cell Growth Differ. 6(10):1995;1251-1259.
    • (1995) Cell Growth Differ , vol.6 , Issue.10 , pp. 1251-1259
    • Batra, S.K.1    Castelino-Prabhu, S.2    Wikstrand, C.J.3    Zhu, X.4    Humphrey, P.A.5    Friedman, H.S.6    Bigner, D.D.7
  • 9
    • 0035001584 scopus 로고    scopus 로고
    • Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx
    • Bier H., Hoffmann T., Hauser U., Wink M., Ochler M., Kovar A., Muser M., Knecht R. Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72. 000 in patients with advanced squamous cell carcinoma of the larynx and hypopharynx Cancer Chemother Pharmacol. 47(6):2001;519-524.
    • (2001) Cancer Chemother Pharmacol , vol.47 , Issue.6 , pp. 519-524
    • Bier, H.1    Hoffmann, T.2    Hauser, U.3    Wink, M.4    Ochler, M.5    Kovar, A.6    Muser, M.7    Knecht, R.8
  • 10
    • 0032525784 scopus 로고    scopus 로고
    • The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system
    • Britsch S., Li L., Kirchhoff S., Theuring F., Brinkmann V., Birchmeier C., Riethmacher D. The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. Genes Dev. 12(12):1998;1825-1836.
    • (1998) Genes Dev , vol.12 , Issue.12 , pp. 1825-1836
    • Britsch, S.1    Li, L.2    Kirchhoff, S.3    Theuring, F.4    Brinkmann, V.5    Birchmeier, C.6    Riethmacher, D.7
  • 12
    • 0036554816 scopus 로고    scopus 로고
    • Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention
    • Buettner R., Mora L.B., Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res. 8(4):2002;945-954.
    • (2002) Clin Cancer Res , vol.8 , Issue.4 , pp. 945-954
    • Buettner, R.1    Mora, L.B.2    Jove, R.3
  • 13
    • 0032894071 scopus 로고    scopus 로고
    • The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix
    • Chang J.L., Tsao Y.P., Liu D.W., Han C.P., Lee W.H., Chen S.L. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix. Gynecol Oncol. 73(1):1999;62-71.
    • (1999) Gynecol Oncol , vol.73 , Issue.1 , pp. 62-71
    • Chang, J.L.1    Tsao, Y.P.2    Liu, D.W.3    Han, C.P.4    Lee, W.H.5    Chen, S.L.6
  • 14
    • 0030980531 scopus 로고    scopus 로고
    • Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer
    • Chow N.H., Liu H.S., Lee E.I., Chang C.J., Chan S.H., Cheng H.L., Tzai T.S., Lin J.S. Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer. Anticancer Res. 17(2B):1997;1293-1296.
    • (1997) Anticancer Res , vol.17 , Issue.2 B , pp. 1293-1296
    • Chow, N.H.1    Liu, H.S.2    Lee, E.I.3    Chang, C.J.4    Chan, S.H.5    Cheng, H.L.6    Tzai, T.S.7    Lin, J.S.8
  • 15
    • 0037302445 scopus 로고    scopus 로고
    • Epidermal growth factor receptor as a therapeutic target in colorectal cancer
    • Cohen R.B. Epidermal growth factor receptor as a therapeutic target in colorectal cancer. Clin Colorectal Cancer. 2(4):2003;246-251.
    • (2003) Clin Colorectal Cancer , vol.2 , Issue.4 , pp. 246-251
    • Cohen, R.B.1
  • 16
    • 0001303067 scopus 로고    scopus 로고
    • Phase II study of ZD1839 (Iressa) in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN)
    • (899)
    • Cohen E., Rosen F., Dekker A.et al. Phase II study of ZD1839 (Iressa) in recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Proc Am Soc Clin Oncol. 21:2002;225a. (899).
    • (2002) Proc Am Soc Clin Oncol , vol.21
    • Cohen, E.1    Rosen, F.2    Dekker, A.3
  • 17
    • 0037336316 scopus 로고    scopus 로고
    • Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody h-R3, in patients with advanced epithelial-derived cancer
    • Crombet T., Torres L., Neninger E., Catala M., Solano M.E., Perera A., Torres O., Iznaga N., Torres F., Perez R., Lage A. Pharmacological evaluation of humanized anti-epidermal growth factor receptor, monoclonal antibody h-R3, in patients with advanced epithelial-derived cancer. J Immunother. 26(2):2003;139-148.
    • (2003) J Immunother , vol.26 , Issue.2 , pp. 139-148
    • Crombet, T.1    Torres, L.2    Neninger, E.3    Catala, M.4    Solano, M.E.5    Perera, A.6    Torres, O.7    Iznaga, N.8    Torres, F.9    Perez, R.10    Lage, A.11
  • 18
    • 0030727901 scopus 로고    scopus 로고
    • Clinical experience with CD64-directed immunotherapy. An overview
    • Curnow R.T. Clinical experience with CD64-directed immunotherapy. An overview. Cancer Immunol Immunother. 45(3-4):1997;210-215.
    • (1997) Cancer Immunol Immunother , vol.45 , Issue.34 , pp. 210-215
    • Curnow, R.T.1
  • 19
    • 0036132083 scopus 로고    scopus 로고
    • Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype
    • Damstrup L., Wandahl Pedersen M., Bastholm L., Elling F., Skovgaard Poulsen H. Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype. Int J Cancer. 97(1):2002;7-14.
    • (2002) Int J Cancer , vol.97 , Issue.1 , pp. 7-14
    • Damstrup, L.1    Wandahl Pedersen, M.2    Bastholm, L.3    Elling, F.4    Skovgaard Poulsen, H.5
  • 20
    • 0030683639 scopus 로고    scopus 로고
    • Signal characteristics of G protein-transactivated EGF receptor
    • Daub H., Wallasch C., Lankenau A., Herrlich A., Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J. 16(23):1997;7032-7044.
    • (1997) EMBO J , vol.16 , Issue.23 , pp. 7032-7044
    • Daub, H.1    Wallasch, C.2    Lankenau, A.3    Herrlich, A.4    Ullrich, A.5
  • 22
    • 0001100601 scopus 로고    scopus 로고
    • A phase I and pharmacological study of PKI166, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, administered orally 3 times a week to patients with advanced cancer
    • (Abstract 341)
    • Dumez H., Hoekstra R., Eskens F., Sizer K.C., Vaidyanathan S., Ravera C., van Oosterom A.T., Verweij J., Gasthuisberg U.Z. A phase I and pharmacological study of PKI166, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, administered orally 3 times a week to patients with advanced cancer. Proc Am Soc Clin Oncol. 2002;. (Abstract 341).
    • (2002) Proc Am Soc Clin Oncol
    • Dumez, H.1    Hoekstra, R.2    Eskens, F.3    Sizer, K.C.4    Vaidyanathan, S.5    Ravera, C.6    Van Oosterom, A.T.7    Verweij, J.8    Gasthuisberg, U.Z.9
  • 23
    • 0025790916 scopus 로고
    • Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo
    • Ekstrand A.J., James C.D., Cavenee W.K., Seliger B., Pettersson R.F., Collins V.P. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 51(8):1991;2164-2172.
    • (1991) Cancer Res , vol.51 , Issue.8 , pp. 2164-2172
    • Ekstrand, A.J.1    James, C.D.2    Cavenee, W.K.3    Seliger, B.4    Pettersson, R.F.5    Collins, V.P.6
  • 25
    • 0031454062 scopus 로고    scopus 로고
    • ErbB3 is required for normal cerebellar and cardiac development: A comparison with ErbB2- and heregulin-deficient mice
    • Erickson S.L., O'Shea K.S., Ghaboosi N., Loverro L., Frantz G., Bauer M., Lu L.H., Moore M.W. ErbB3 is required for normal cerebellar and cardiac development: A comparison with ErbB2- and heregulin-deficient mice. Development. 124(24):1997;4999-5011.
    • (1997) Development , vol.124 , Issue.24 , pp. 4999-5011
    • Erickson, S.L.1    O'Shea, K.S.2    Ghaboosi, N.3    Loverro, L.4    Frantz, G.5    Bauer, M.6    Lu, L.H.7    Moore, M.W.8
  • 26
    • 0032763824 scopus 로고    scopus 로고
    • Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens
    • Feldkamp M.M., Lala P., Lau N., Roncari L., Guha A. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery. 45(6):1999;1442-1453.
    • (1999) Neurosurgery , vol.45 , Issue.6 , pp. 1442-1453
    • Feldkamp, M.M.1    Lala, P.2    Lau, N.3    Roncari, L.4    Guha, A.5
  • 27
    • 0031056372 scopus 로고    scopus 로고
    • EGFR and steroid receptors in ovarian carcinoma: Comparison with prognostic parameters and outcome of patients
    • Fischer-Colbrie J., Witt A., Heinzl H., Speiser P., Czerwenka K., Sevelda P., Zeillinger R. EGFR and steroid receptors in ovarian carcinoma: Comparison with prognostic parameters and outcome of patients. Anticancer Res. 17(1B):1997;613-619.
    • (1997) Anticancer Res , vol.17 , Issue.1 B , pp. 613-619
    • Fischer-Colbrie, J.1    Witt, A.2    Heinzl, H.3    Speiser, P.4    Czerwenka, K.5    Sevelda, P.6    Zeillinger, R.7
  • 28
    • 0036118262 scopus 로고    scopus 로고
    • Epidermal growth factor receptor family in lung cancer and premalignancy
    • Franklin W.A., Veve R., Hirsch F.R., Helfrich B.A., Bunn P.A. Jr. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin Oncol. 29(1 Suppl. 4):2002;3-14.
    • (2002) Semin Oncol , vol.29 , Issue.1 SUPPL. 4 , pp. 3-14
    • Franklin, W.A.1    Veve, R.2    Hirsch, F.R.3    Helfrich, B.A.4    Bunn, P.A.Jr.5
  • 29
    • 0030297662 scopus 로고    scopus 로고
    • A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer
    • Fujino S., Enokibori T., Tezuka N., Asada Y., Inoue S., Kato H., Mori A. A comparison of epidermal growth factor receptor levels and other prognostic parameters in non-small cell lung cancer. Eur J Cancer. 32A(12):1996;2070-2074.
    • (1996) Eur J Cancer , vol.32 , Issue.12 , pp. 2070-2074
    • Fujino, S.1    Enokibori, T.2    Tezuka, N.3    Asada, Y.4    Inoue, S.5    Kato, H.6    Mori, A.7
  • 33
    • 0002806626 scopus 로고    scopus 로고
    • A phase III clinical trial of ZD1839 ('Iressa') in combination with gemcitabine and cisplatin in chemotherapy-naive patients with advanced non-small-call lung cancer
    • (Abstract 40)
    • Giaccone G.A. A phase III clinical trial of ZD1839 ('Iressa') in combination with gemcitabine and cisplatin in chemotherapy-naive patients with advanced non-small-call lung cancer. Ann Oncol. 13:2002;2. (Abstract 40).
    • (2002) Ann Oncol , vol.13 , pp. 2
    • Giaccone, G.A.1
  • 34
    • 0001744237 scopus 로고    scopus 로고
    • Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines
    • Grandis J.R., Zeng Q., Tweardy D.J. Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines. Nat Med. 2(2):1996;237-240.
    • (1996) Nat Med , vol.2 , Issue.2 , pp. 237-240
    • Grandis, J.R.1    Zeng, Q.2    Tweardy, D.J.3
  • 35
    • 0013689209 scopus 로고    scopus 로고
    • Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro
    • Grandis J.R., Drenning S.D., Chakraborty A., Zhou M.Y., Zeng Q., Pitt A.S., Tweardy D.J. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J Clin Invest. 102(7):1998;1385-1392.
    • (1998) J Clin Invest , vol.102 , Issue.7 , pp. 1385-1392
    • Grandis, J.R.1    Drenning, S.D.2    Chakraborty, A.3    Zhou, M.Y.4    Zeng, Q.5    Pitt, A.S.6    Tweardy, D.J.7
  • 37
    • 0038718522 scopus 로고    scopus 로고
    • Developing inhibitors of the epidermal growth factor receptor for cancer treatment
    • Grunwald V., Hidalgo M. Developing inhibitors of the epidermal growth factor receptor for cancer treatment. J Natl Cancer Inst. 95(12):2003;851-867.
    • (2003) J Natl Cancer Inst , vol.95 , Issue.12 , pp. 851-867
    • Grunwald, V.1    Hidalgo, M.2
  • 38
    • 0032528051 scopus 로고    scopus 로고
    • Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter
    • He Y., Zeng Q., Drenning S.D., Melhem M.F., Tweardy D.J., Huang L., Grandis J.R. Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter. J Natl Cancer Inst. 90(14):1998;1080-1087.
    • (1998) J Natl Cancer Inst , vol.90 , Issue.14 , pp. 1080-1087
    • He, Y.1    Zeng, Q.2    Drenning, S.D.3    Melhem, M.F.4    Tweardy, D.J.5    Huang, L.6    Grandis, J.R.7
  • 39
    • 0036124415 scopus 로고    scopus 로고
    • Epidermal growth factor receptors as a target for cancer treatment: The emerging role of IMC-C225 in the treatment of lung and head and neck cancers
    • Herbst R.S., Langer C.J. Epidermal growth factor receptors as a target for cancer treatment: The emerging role of IMC-C225 in the treatment of lung and head and neck cancers. Semin Oncol. 29(1 Suppl. 4):2002;27-36.
    • (2002) Semin Oncol , vol.29 , Issue.1 SUPPL. 4 , pp. 27-36
    • Herbst, R.S.1    Langer, C.J.2
  • 40
    • 0036500831 scopus 로고    scopus 로고
    • Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: A new paradigm for cancer therapy
    • Herbst R.S., Shin D.M. Monoclonal antibodies to target epidermal growth factor receptor-positive tumors: a new paradigm for cancer therapy. Cancer. 94(5):2002;1593-1611.
    • (2002) Cancer , vol.94 , Issue.5 , pp. 1593-1611
    • Herbst, R.S.1    Shin, D.M.2
  • 41
    • 0002462661 scopus 로고    scopus 로고
    • Inhibition of the epidermal growth factor receptor (EGFR) by OSI-774, a specific EGFR inhibitor in malignant and normal tissues of cancer patients
    • (281)
    • Hidalgo M., Malik S., Rowinsky E.et al. Inhibition of the epidermal growth factor receptor (EGFR) by OSI-774, a specific EGFR inhibitor in malignant and normal tissues of cancer patients. Proc Am Soc Clin Oncol. 20:2001;71a. (281).
    • (2001) Proc Am Soc Clin Oncol , vol.20
    • Hidalgo, M.1    Malik, S.2    Rowinsky, E.3
  • 43
    • 0001100601 scopus 로고    scopus 로고
    • A phase I and pharmacological study of PKI166, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, administered orally in a two weeks on, two weeks off scheme to patients with advanced cancer
    • (Abstract # 340)
    • Hoekstra R., Dumez H., van Oosterom A.T., Sizer K.C., Ravera C., Vaidyanathan S., Verweij J., Eskens F.A. A phase I and pharmacological study of PKI166, an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, administered orally in a two weeks on, two weeks off scheme to patients with advanced cancer. Proc Am Soc Clin Oncol. 21:2002;86a. (Abstract # 340).
    • (2002) Proc Am Soc Clin Oncol , vol.21
    • Hoekstra, R.1    Dumez, H.2    Van Oosterom, A.T.3    Sizer, K.C.4    Ravera, C.5    Vaidyanathan, S.6    Verweij, J.7    Eskens, F.A.8
  • 44
    • 0030499589 scopus 로고    scopus 로고
    • Overexpression of EGF receptor is associated with spontaneous metastases of a human melanoma cell line in nude mice
    • Huang T.S., Rauth S., Das Gupta T.K. Overexpression of EGF receptor is associated with spontaneous metastases of a human melanoma cell line in nude mice. Anticancer Res. 16(6B):1996;3557-3563.
    • (1996) Anticancer Res , vol.16 , Issue.6 B , pp. 3557-3563
    • Huang, T.S.1    Rauth, S.2    Das Gupta, T.K.3
  • 45
    • 0000780450 scopus 로고    scopus 로고
    • ('Iressa') in combination with paclitaxel and carboplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) results from a phase III clinical trial
    • (Abstract 4680)
    • Johnson D.H. ('Iressa') in combination with paclitaxel and carboplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) results from a phase III clinical trial. Ann Oncol. 13:2002;127. (Abstract 4680).
    • (2002) Ann Oncol , vol.13 , pp. 127
    • Johnson, D.H.1
  • 46
    • 0033009389 scopus 로고    scopus 로고
    • Binding specificities and affinities of egf domains for ErbB receptors
    • Jones J.T., Akita R.W., Sliwkowski M.X. Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett. 447(2-3):1999;227-231.
    • (1999) FEBS Lett , vol.447 , Issue.23 , pp. 227-231
    • Jones, J.T.1    Akita, R.W.2    Sliwkowski, M.X.3
  • 47
    • 0026571910 scopus 로고
    • The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review on 5232 patients
    • Klijn J.G., Berns P.M., Schmitz P.I., Foekens J.A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review on 5232 patients. Endocr Rev. 13(1):1992;3-17.
    • (1992) Endocr Rev , vol.13 , Issue.1 , pp. 3-17
    • Klijn, J.G.1    Berns, P.M.2    Schmitz, P.I.3    Foekens, J.A.4
  • 48
    • 0031466502 scopus 로고    scopus 로고
    • Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4
    • Komurasaki T., Toyoda H., Uchida D., Morimoto S. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene. 15(23):1997;2841-2848.
    • (1997) Oncogene , vol.15 , Issue.23 , pp. 2841-2848
    • Komurasaki, T.1    Toyoda, H.2    Uchida, D.3    Morimoto, S.4
  • 50
    • 0031858266 scopus 로고    scopus 로고
    • The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions
    • Leav I., McNeal J.E., Ziar J., Alroy J. The localization of transforming growth factor alpha and epidermal growth factor receptor in stromal and epithelial compartments of developing human prostate and hyperplastic, dysplastic, and carcinomatous lesions. Hum Pathol. 29(7):1998;668-675.
    • (1998) Hum Pathol , vol.29 , Issue.7 , pp. 668-675
    • Leav, I.1    McNeal, J.E.2    Ziar, J.3    Alroy, J.4
  • 51
    • 0028858730 scopus 로고
    • Overexpression of phospholipase C-gamma 1 in colorectal carcinomas is associated with overexpression of factors that bind its promoter
    • Lee S.J., Lee S.D., Park J.G., Kim C.M., Ryu S.H., Suh P.G. Overexpression of phospholipase C-gamma 1 in colorectal carcinomas is associated with overexpression of factors that bind its promoter. J Biol Chem. 270(27):1995;16378-16384.
    • (1995) J Biol Chem , vol.270 , Issue.27 , pp. 16378-16384
    • Lee, S.J.1    Lee, S.D.2    Park, J.G.3    Kim, C.M.4    Ryu, S.H.5    Suh, P.G.6
  • 52
    • 0027987263 scopus 로고
    • Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins
    • Li N., Schlessinger J., Margolis B. Autophosphorylation mutants of the EGF-receptor signal through auxiliary mechanisms involving SH2 domain proteins. Oncogene. 9(12):1994;3457-3465.
    • (1994) Oncogene , vol.9 , Issue.12 , pp. 3457-3465
    • Li, N.1    Schlessinger, J.2    Margolis, B.3
  • 53
    • 0037044783 scopus 로고    scopus 로고
    • Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha
    • McCole D.F., Keely S.J., Coffey R.J., Barrett K.E. Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J Biol Chem. 277(45):2002;42603-42612.
    • (2002) J Biol Chem , vol.277 , Issue.45 , pp. 42603-42612
    • McCole, D.F.1    Keely, S.J.2    Coffey, R.J.3    Barrett, K.E.4
  • 54
    • 0031800885 scopus 로고    scopus 로고
    • EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma
    • Messa C., Russo F., Caruso M.G., Di Leo A. EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma. Acta Oncol. 37(3):1998;285-289.
    • (1998) Acta Oncol , vol.37 , Issue.3 , pp. 285-289
    • Messa, C.1    Russo, F.2    Caruso, M.G.3    Di Leo, A.4
  • 55
    • 0027732568 scopus 로고
    • New Gaba-containing analogues of human growth hormone-releasing hormone (1-30)-amide: I. Synthesis and in vitro biological activity
    • Mezo I., Kovacs M., Szoke B., Szabo E.Z., Horvath J., Makara G.B., Rappay G., Tamas J., Teplan I. New Gaba-containing analogues of human growth hormone-releasing hormone (1-30)-amide: I. Synthesis and in vitro biological activity. J Endocrinol Invest. 16(10):1993;793-798.
    • (1993) J Endocrinol Invest , vol.16 , Issue.10 , pp. 793-798
    • Mezo, I.1    Kovacs, M.2    Szoke, B.3    Szabo, E.Z.4    Horvath, J.5    Makara, G.B.6    Rappay, G.7    Tamas, J.8    Teplan, I.9
  • 56
    • 0029074587 scopus 로고
    • Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor
    • Miettinen P.J., Berger J.E., Meneses J., Phung Y., Pedersen R.A., Werb Z., Derynck R. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature. 376(6538):1995;337-341.
    • (1995) Nature , vol.376 , Issue.6538 , pp. 337-341
    • Miettinen, P.J.1    Berger, J.E.2    Meneses, J.3    Phung, Y.4    Pedersen, R.A.5    Werb, Z.6    Derynck, R.7
  • 57
    • 0029063936 scopus 로고
    • The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor
    • Miller W.E., Earp H.S., Raab-Traub N. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol. 69(7):1995;4390-4398.
    • (1995) J Virol , vol.69 , Issue.7 , pp. 4390-4398
    • Miller, W.E.1    Earp, H.S.2    Raab-Traub, N.3
  • 59
    • 0029666423 scopus 로고    scopus 로고
    • Transformational and altered signal transduction by a naturally occurring mutant EGF receptor
    • Moscatello D.K., Montgomery R.B., Sundareshan P., McDanel H., Wong M.Y., Wong A.J. Transformational and altered signal transduction by a naturally occurring mutant EGF receptor. Oncogene. 13(1):1996;85-96.
    • (1996) Oncogene , vol.13 , Issue.1 , pp. 85-96
    • Moscatello, D.K.1    Montgomery, R.B.2    Sundareshan, P.3    McDanel, H.4    Wong, M.Y.5    Wong, A.J.6
  • 60
    • 0031961980 scopus 로고    scopus 로고
    • Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor
    • Moscatello D.K., Holgado-Madruga M., Emlet D.R., Montgomery R.B., Wong A.J. Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor. J Biol Chem. 273(1):1998;200-206.
    • (1998) J Biol Chem , vol.273 , Issue.1 , pp. 200-206
    • Moscatello, D.K.1    Holgado-Madruga, M.2    Emlet, D.R.3    Montgomery, R.B.4    Wong, A.J.5
  • 62
    • 0034833599 scopus 로고    scopus 로고
    • Quantitation of epidermal growth factor receptor gene amplification by competitive polymerase chain reaction in pre-malignant and malignant oral epithelial lesions
    • Nagatsuka H., Ishiwari Y., Tsujigiwa H., Nakano K., Nagai N. Quantitation of epidermal growth factor receptor gene amplification by competitive polymerase chain reaction in pre-malignant and malignant oral epithelial lesions. Oral Oncol. 37(7):2001;599-604.
    • (2001) Oral Oncol , vol.37 , Issue.7 , pp. 599-604
    • Nagatsuka, H.1    Ishiwari, Y.2    Tsujigiwa, H.3    Nakano, K.4    Nagai, N.5
  • 63
    • 0037112423 scopus 로고    scopus 로고
    • Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas
    • Narita Y., Nagane M., Mishima K., Huang H.J., Furnari F.B., Cavenee W.K. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas. Cancer Res. 62(22):2002;6764-6769.
    • (2002) Cancer Res , vol.62 , Issue.22 , pp. 6764-6769
    • Narita, Y.1    Nagane, M.2    Mishima, K.3    Huang, H.J.4    Furnari, F.B.5    Cavenee, W.K.6
  • 64
    • 0035282696 scopus 로고    scopus 로고
    • Fluorescent RNA cytochemistry: Tracking gene transcripts in living cells
    • Pederson T. Fluorescent RNA cytochemistry: Tracking gene transcripts in living cells. Nucleic Acids Res. 29(5):2001;1013-1016.
    • (2001) Nucleic Acids Res , vol.29 , Issue.5 , pp. 1013-1016
    • Pederson, T.1
  • 66
    • 0029815093 scopus 로고    scopus 로고
    • Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway
    • Prigent S.A., Nagane M., Lin H., Huvar I., Boss G.R., Feramisco J.R., Cavenee W.K., Huang H.S. Enhanced tumorigenic behavior of glioblastoma cells expressing a truncated epidermal growth factor receptor is mediated through the Ras-Shc-Grb2 pathway. J Biol Chem. 271(41):1996;25639-25645.
    • (1996) J Biol Chem , vol.271 , Issue.41 , pp. 25639-25645
    • Prigent, S.A.1    Nagane, M.2    Lin, H.3    Huvar, I.4    Boss, G.R.5    Feramisco, J.R.6    Cavenee, W.K.7    Huang, H.S.8
  • 67
    • 0031936410 scopus 로고    scopus 로고
    • Specificity within the EGF family/ErbB receptor family signaling network
    • Riese D.J. II, Stern D.F. Specificity within the EGF family/ErbB receptor family signaling network. BioEssays. 20(1):1998;41-48.
    • (1998) BioEssays , vol.20 , Issue.1 , pp. 41-48
    • Riese II, D.J.1    Stern, D.F.2
  • 68
    • 0031657830 scopus 로고    scopus 로고
    • A comparative study of epidermal growth factor receptor (EGFR) and MDM2 gene amplification and protein immunoreactivity in human glioblastomas
    • Rieske P., Kordek R., Bartkowiak J., Debiec-Rychter M., Biernat W., Liberski P.P. A comparative study of epidermal growth factor receptor (EGFR) and MDM2 gene amplification and protein immunoreactivity in human glioblastomas. Pol J Pathol. 49(3):1998;145-149.
    • (1998) Pol J Pathol , vol.49 , Issue.3 , pp. 145-149
    • Rieske, P.1    Kordek, R.2    Bartkowiak, J.3    Debiec-Rychter, M.4    Biernat, W.5    Liberski, P.P.6
  • 71
    • 0001744237 scopus 로고    scopus 로고
    • Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines
    • Rubin Grandis J., Zeng Q., Tweardy D.J. Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines. Nat Med. 2(2):1996;237-240.
    • (1996) Nat Med , vol.2 , Issue.2 , pp. 237-240
    • Rubin Grandis, J.1    Zeng, Q.2    Tweardy, D.J.3
  • 72
    • 0029831041 scopus 로고    scopus 로고
    • Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck
    • Rubin Grandis J., Melhem M.F., Barnes E.L., Tweardy D.J. Quantitative immunohistochemical analysis of transforming growth factor-alpha and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck. Cancer. 78(6):1996;1284-1292.
    • (1996) Cancer , vol.78 , Issue.6 , pp. 1284-1292
    • Rubin Grandis, J.1    Melhem, M.F.2    Barnes, E.L.3    Tweardy, D.J.4
  • 73
    • 0030757686 scopus 로고    scopus 로고
    • Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells
    • Rubin Grandis J., Chakraborty A., Melhem M.F., Zeng Q., Tweardy D.J. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. Oncogene. 15(4):1997;409-416.
    • (1997) Oncogene , vol.15 , Issue.4 , pp. 409-416
    • Rubin Grandis, J.1    Chakraborty, A.2    Melhem, M.F.3    Zeng, Q.4    Tweardy, D.J.5
  • 74
    • 0013650320 scopus 로고    scopus 로고
    • Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma
    • Rubin Grandis J., Tweardy D.J., Melhem M.F. Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Clin Cancer Res. 4(1):1998;13-20.
    • (1998) Clin Cancer Res , vol.4 , Issue.1 , pp. 13-20
    • Rubin Grandis, J.1    Tweardy, D.J.2    Melhem, M.F.3
  • 76
    • 0030980781 scopus 로고    scopus 로고
    • Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression
    • Rusch V., Klimstra D., Venkatraman E., Pisters P.W., Langenfeld J., Dmitrovsky E. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res. 3(4):1997;515-522.
    • (1997) Clin Cancer Res , vol.3 , Issue.4 , pp. 515-522
    • Rusch, V.1    Klimstra, D.2    Venkatraman, E.3    Pisters, P.W.4    Langenfeld, J.5    Dmitrovsky, E.6
  • 77
    • 0028955388 scopus 로고
    • Epidermal growth factor-related peptides and their receptors in human malignancies
    • Salomon D.S. Epidermal growth factor-related peptides and their receptors in human malignancies. Oncol Hematol. 19:1995;183-232.
    • (1995) Oncol Hematol , vol.19 , pp. 183-232
    • Salomon, D.S.1
  • 78
    • 0026793456 scopus 로고
    • Growth factor signaling by receptor tyrosine kinases
    • Schlessinger J., Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron. 9(3):1992;383-391.
    • (1992) Neuron , vol.9 , Issue.3 , pp. 383-391
    • Schlessinger, J.1    Ullrich, A.2
  • 79
    • 0031005779 scopus 로고    scopus 로고
    • A thousand and one roles for the Drosophila EGF receptor
    • Schweitzer R., Shilo B.Z. A thousand and one roles for the Drosophila EGF receptor. Trends Genet. 13(5):1997;191-196.
    • (1997) Trends Genet , vol.13 , Issue.5 , pp. 191-196
    • Schweitzer, R.1    Shilo, B.Z.2
  • 81
    • 0035168761 scopus 로고    scopus 로고
    • CI-1033, a pan-erbB tyrosine kinase inhibitor
    • Slichenmyer W.J., Elliott W.L., Fry D.W. CI-1033, a pan-erbB tyrosine kinase inhibitor. Semin Oncol. 28(5 Suppl. 16):2001;80-85.
    • (2001) Semin Oncol , vol.28 , Issue.5 SUPPL. 16 , pp. 80-85
    • Slichenmyer, W.J.1    Elliott, W.L.2    Fry, D.W.3
  • 82
    • 0035205190 scopus 로고    scopus 로고
    • Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry
    • Srinivasan M., Jewell S.D. Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. Oncology. 61(4):2001;284-292.
    • (2001) Oncology , vol.61 , Issue.4 , pp. 284-292
    • Srinivasan, M.1    Jewell, S.D.2
  • 83
    • 0031452314 scopus 로고    scopus 로고
    • Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer
    • Uegaki K., Nio Y., Inoue Y., Minari Y., Sato Y., Song M.M., Dong M., Tamura K. Clinicopathological significance of epidermal growth factor and its receptor in human pancreatic cancer. Anticancer Res. 17(5B):1997;3841-3847.
    • (1997) Anticancer Res , vol.17 , Issue.5 B , pp. 3841-3847
    • Uegaki, K.1    Nio, Y.2    Inoue, Y.3    Minari, Y.4    Sato, Y.5    Song, M.M.6    Dong, M.7    Tamura, K.8
  • 84
    • 0026955947 scopus 로고
    • Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas
    • Visakorpi T., Kallioniemi O.P., Koivula T., Harvey J., Isola J. Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas. Mod Pathol. 5(6):1992;643-648.
    • (1992) Mod Pathol , vol.5 , Issue.6 , pp. 643-648
    • Visakorpi, T.1    Kallioniemi, O.P.2    Koivula, T.3    Harvey, J.4    Isola, J.5
  • 85
    • 0032927489 scopus 로고    scopus 로고
    • Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas
    • Walker R.A., Dearing S.J. Expression of epidermal growth factor receptor mRNA and protein in primary breast carcinomas. Breast Cancer Res Treat. 53(2):1999;167-176.
    • (1999) Breast Cancer Res Treat , vol.53 , Issue.2 , pp. 167-176
    • Walker, R.A.1    Dearing, S.J.2
  • 86
    • 0033369780 scopus 로고    scopus 로고
    • Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity
    • Werkmeister R., Brandt B., Joos U. Aberrations of erbB-1 and erbB-2 oncogenes in non-dysplastic leukoplakias of the oral cavity. Br J Oral Maxillofac Surg. 37(6):1999;477-480.
    • (1999) Br J Oral Maxillofac Surg , vol.37 , Issue.6 , pp. 477-480
    • Werkmeister, R.1    Brandt, B.2    Joos, U.3
  • 88
    • 0030832167 scopus 로고    scopus 로고
    • Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII
    • Wikstrand C.J., McLendon R.E., Friedman A.H., Bigner D.D. Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII. Cancer Res. 57(18):1997;4130-4140.
    • (1997) Cancer Res , vol.57 , Issue.18 , pp. 4130-4140
    • Wikstrand, C.J.1    McLendon, R.E.2    Friedman, A.H.3    Bigner, D.D.4
  • 90
    • 0030936677 scopus 로고    scopus 로고
    • Studies of the expression of epidermal growth factor receptor in human renal cell carcinoma: A comparison of immunohistochemical method versus ligand binding assay
    • Yoshida K., Hosoya Y., Sumi S., Honda M., Moriguchi H., Yano M., Ueda Y. Studies of the expression of epidermal growth factor receptor in human renal cell carcinoma: a comparison of immunohistochemical method versus ligand binding assay. Oncology. 54(3):1997;220-225.
    • (1997) Oncology , vol.54 , Issue.3 , pp. 220-225
    • Yoshida, K.1    Hosoya, Y.2    Sumi, S.3    Honda, M.4    Moriguchi, H.5    Yano, M.6    Ueda, Y.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.